CD274 and neoplasm: This treatment modality resulted in tumor growth inhibition and conferred better survival benefits than IT-administered PBS, free anti-PD-L1, anti-PD-L1-loaded hydrogel, free Dox, Dox-loaded hydrogel, and combined free anti-PD-L1 plus Dox controls.